BeyondSpring Inc. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
BeyondSpring Inc. (BYSI) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$1.75 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-14
- BeyondSpring Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$1.75M.
- BeyondSpring Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$2.35M.
- BeyondSpring Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$2.51M.
- BeyondSpring Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$1.74M.
- BeyondSpring Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was -$8.71M.
- BeyondSpring Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was -$8.87M.
- BeyondSpring Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was -$14.02M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.75M 10-Q · filed 2026-08-14 | -$4.10M 10-Q · filed 2026-08-14 | -$6.61M derived: sum of 3 quarters · filed 2026-08-14 | -$8.35M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$2.35M 10-Q · filed 2026-05-13 | -$4.86M derived: sum of 2 quarters · filed 2026-05-13 | -$6.60M derived: sum of 3 quarters · filed 2026-05-13 | -$8.48M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$4.25M derived: sum of 2 quarters · filed 2026-03-25 | -$6.13M derived: sum of 3 quarters · filed 2026-08-14 | -$8.71M 10-K · filed 2026-03-25 |
| 2025-09-30 | -$1.74M 10-Q · filed 2025-11-12 | -$3.62M derived: sum of 2 quarters · filed 2026-08-14 | -$6.21M 10-Q · filed 2025-11-12 | -$8.12M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$1.88M 10-Q · filed 2026-08-14 | -$4.46M 10-Q · filed 2026-08-14 | -$6.38M derived: sum of 3 quarters · filed 2026-08-14 | -$8.60M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$2.58M 10-Q · filed 2026-05-13 | -$4.50M derived: sum of 2 quarters · filed 2026-05-13 | -$6.72M derived: sum of 3 quarters · filed 2026-05-13 | -$9.37M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$4.13M derived: sum of 2 quarters · filed 2026-03-25 | -$6.79M derived: sum of 3 quarters · filed 2026-03-25 | -$8.87M 10-K · filed 2026-03-25 |
| 2024-09-30 | -$2.21M 10-Q · filed 2025-11-12 | -$4.87M derived: sum of 2 quarters · filed 2025-11-12 | -$6.95M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$2.65M 10-Q · filed 2025-08-13 | -$4.73M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$2.08M 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$14.02M 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |